Concepedia
Statistics
Publications
2
Citations
37
H-Index
Active since
2024
Affiliations
WinnMed(Current)
Eric P. Grewal is an author at WinnMed specializing in pharmacy, targeted cancer therapy, and phase ii investigation.
Publications per year
2024–2024
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial
Tina J. Hieken, Garth D. Nelson, Thomas J. Flotte et al. · Nature Communications · 2024 · 26 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +17
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma
Eric P. Grewal, Leland G. Richardson, Jing Sun et al. · Clinical Cancer Research · 2024 · 11 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–2 of 2